Fundz

Real-time funding, M&A, exec moves & hiring — the signals that move deals

More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.

The funding market, moving in real timeBook a DemoChoose your plan
Loading live signals…

Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.

Back to SEC Filings
Executive ChangeItem 5.02 · 8-KLOW RiskNeutral

Evolent Health, Inc.

Filed: Jun 4, 2026CIK: 0001628908
View on SEC.gov

AI Executive Summary

AI-powered analysis of 8-K filing content

Evolent Health held its 2026 Annual Meeting of Stockholders on June 4, 2026, where stockholders elected ten director nominees to the Board of Directors for one-year terms, reflecting a governance structure change with potential implications for the company's strategic direction.

Key Takeaways

Ten directors were successfully elected to the Board for one-year terms at the 2026 Annual Meeting

The election reflects a change in governance structure that could influence strategic decisions

2 more takeaways

Filing Overview

Form Type8-K
Filing DateJun 4, 2026
Item5.02
CategoryExecutive Change
CIK0001628908
Accession #evh-20260604
Risk LevelLOW
SentimentNeutral
Signalinformational
Topics
board change

What This Means

A senior executive (CEO, CFO, etc.) has joined, departed, or changed roles. Leadership changes can significantly impact strategy.
View Full Filing on SEC.govBrowse More Filings